Loading...
Futura Medical plc
FUM.L•LSE
Healthcare
Biotechnology
£12.50
£0.25(2.04%)
Futura Medical plc (FUM.L) Company Profile & Overview
Explore Futura Medical plc’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.
Futura Medical plc (FUM.L) Company Profile & Overview
Futura Medical plc, a pharmaceutical company, develops pharmaceutical and healthcare products for the consumer healthcare markets focusing on sexual health and pain relief management. Its lead product is MED3000, a topical gel for the treatment of erectile dysfunction. The company also develops pain relief products, including TPR100, a topical diclofenac pain relief gel; CBD100, a topical cannabidiol formulation; and TIB200, a topical ibuprofen pain relief gel. The company was incorporated in 2001 and is headquartered in Guildford, the United Kingdom.
SectorHealthcare
IndustryBiotechnology
CEOJames Henry Barder
Contact Information
Company Facts
14 Employees
IPO DateJul 22, 2003
CountryGB
Actively Trading